Skip to content

MDMA: all studies

Page 239 of 345: studies 2,381 to 2,390 of 3,446, newest first. Back to the MDMA overview

Research

Special issue on illicit drugs

Drug Testing and Analysis September 1, 2011 Simon D. Brandt 5 citations

The agony and the ecstasy associated with the area of illicit drugs is a matter of constant interest today. Prevalence of use, availability of reference standards, and novel detection methods provide many challenging and exciting opportunities, particularly when dealing with increasing levels of novelty and complexity within a globalized world. This special issue aims to present a snapshot of a...

DOI: 10.1002/dta.308 (opens in new tab) Ecstasy Variety cybernetics Drugs of abuse Recreational drug +7

Neuronal Nicotinic Receptors as New Targets for Amphetamine-Induced Oxidative Damage and Neurotoxicity

Pharmaceuticals June 15, 2011 Elena Escubedo, Sara Garcia-Ratés, Jordi Camarasa et al. 4 citations

Amphetamine derivatives such as methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) are widely abused drugs in a recreational context. This has led to concern because of the evidence that they are neurotoxic in animal models and cognitive impairments have been described in heavy abusers. The main targets of these drugs are plasmalemmal and vesicular monoamine...

DOI: 10.3390/ph4060822 (opens in new tab) Full text (opens in new tab) MDMA Methamphetamine Nicotinic Neuroprotection +1

Abuse Liability Profile of Three Substituted Tryptamines

Journal of Pharmacology and Experimental Therapeutics April 8, 2011 Michael B. Gatch, Michael J. Forster, Aaron Janowsky et al. 42 citations

The abuse liability profile of three synthetic hallucinogens, N,N-diisopropyltryptamine (DIPT), 5-N,N-diethyl-5-methoxytryptamine (5-MeO-DET), and 5-methoxy-α-methyltryptamine (5-MeO-AMT), was tested in rats trained to discriminate hallucinogenic and psychostimulant compounds, including cocaine, methamphetamine, 3,4-methylenedioxymethylamphetamine (MDMA), lysergic acid diethylamide (LSD),...

Methylone and Monoamine Transporters: Correlation with Toxicity

Current Neuropharmacology March 1, 2011 Chiharu Sogawa, Norio Sogawa, Kazumi Ohyama et al. 50 citations

Methylone (2-methylamino-1-[3,4-methylenedioxyphenyl]propane-1-one) is a synthetic hallucinogenic amphetamine analog, like MDMA (3,4-methylenedioxy- methamphetamine), considered to act on monoaminergic systems. However, the psychopharmacological profile of its cytotoxicity as a consequence of monoaminergic deficits remains unclear. We examined here the effects of methylone on the transporters...

User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

Journal of Substance Use July 30, 2010 R. L. Carhart-Harris, D. J. Nutt 108 citations

This study used a web-based questionnaire to investigate user perceptions of the benefits and harms of hallucinogenic drug use. Over 600 forms were submitted. Users were asked to comment on the acute and prolonged effects of different drugs and to provide more specific information on how particular drugs have harmed and/or helped them. Subjects reported relatively less harm associated with the...

Near-Death States Reported in a Sample of 50 Misusers

Substance Use & Misuse March 1, 2010 Ornella Corazza, Fabrizio Schifano 43 citations

Increase in recreational ketamine use may be a cause for concern. We aimed here at assessing, in a sample of ketamine misusers, concordance between the typical near-death experience (NDE) features and the on-drug psychoactive effects the subjects experienced. In 2003-2005, a sample of previous ketamine misusers recollecting a ketamine-related NDE were recruited through snowballing and screened...

Amphetamine toxicities

Annals of the New York Academy of Sciences January 8, 2010 Bryan K. Yamamoto, Anna Moszczyńska, Gary A. Gudelsky 280 citations

The drugs of abuse, methamphetamine and MDMA, produce long‐term decreases in markers of biogenic amine neurotransmission. These decreases have been traditionally linked to nerve terminals and are evident in a variety of species, including rodents, nonhuman primates, and humans. Recent studies indicate that the damage produced by these drugs may be more widespread than originally believed....

DOI: 10.1111/j.1749-6632.2009.05141.x (opens in new tab) MDMA Methamphetamine Neurotoxicity Neuroinflammation +2

Harms associated with psychoactive substances: findings of the UK National Drug Survey

Journal of Psychopharmacology November 25, 2009 Celia J. A. Morgan, Leslie Muetzelfeldt, Mark Muetzelfeldt et al. 80 citations

Nutt and colleagues' 'rational' scale to assess the harms of commonly used drugs was based on ratings by a panel of experts. This survey aimed to assess drug users' views of the harms of drugs using the same scale. As users' drug choices are not solely based on harms, we additionally assessed perceived benefits. The survey was hosted at http://www.nationaldrugsurvey.org. UK residents reported...

In Vitro Screening of Psychoactive Drugs to Prevent the Abuses

Yakugaku Zasshi December 1, 2008 Kanako Satoh, Ryouichi Nonaka 4 citations

The Tokyo Metropolitan Government in Japan enacted an "Ordinance concerning the abuse prevention of the psychoactive drugs" in April 2006 that prohibited the manufacture, cultivation, sales, possession, use, etc., of these drugs. Therefore, we constructed a reproducible, simple, and small-scale determination method of the psychoactive drugs for the re-uptake and the release of monoamines...

Stimulatory Drugs of Abuse in Surface Waters and Their Removal in a Conventional Drinking Water Treatment Plant

Environmental Science & Technology August 6, 2008 Maria Huerta‐fontela, Maria Teresa Galceran, Francesc Ventura 218 citations

The presence of psychoactive stimulatory drugs in raw waters used for drinking water production and in finished drinking water was evaluated in a Spanish drinking water treatment plant (DWTP). Contamination of the river basin which provides raw water to this DWTP was also studied. In surface waters, illicit drugs such as cocaine, benzoylecgonine (cocaine metabolite), amphetamine,...

DOI: 10.1021/es800768h (opens in new tab) MDMA Benzoylecgonine Caffeine Metabolite +6